SwedenSkatteverket
Aino Health 2026 issue: N 1:3 at 0,20 kr, first day ex-rights 17/11
Skatteverket adds a 2026 row to Aino Health issue table: N 1:3 at 0,20 kr, first day ex-rights 17/11.
By Taxxa AI OyPublished 18 November 2026
Aino Health AB (organisationsnummer 559063-5073) is listed on First North, first listed on 16 December 2016 at an introductory price of 26 kronor. Skatteverket's share-history page for the company records its corporate actions in the "Emissioner m.m." table, which shareholders and advisers use to compute acquisition cost for capital gains tax on disposals. The page has gained a new 2026 rowSkatteverket: N 1:3
Skatteverket at a subscription price of 0,20 kronor
Skatteverket, with 17/11 as the first day excluding subscription rights
Skatteverket.
The new row means holders of three existing shares could subscribe for one new shareSkatteverket at 0,20 kr
Skatteverketonor per share, and shares traded from 17 November no longer carry the subscription right
Skatteverket. Anyone computing the average acquisition cost (genomsnittsmetoden) for Aino Health shares disposed of during 2026 must reflect this issue alongside the earlier ones in the same table: the 2024 issue N 2:1 at 0,09 kronor with first day ex-rights 5/6, the 2023 issue N 1:1 at 0,30 kronor with first day 9/8, the 2020 issue N 2:3 at 1,50 kronor with first day 15/9, and the 2018 unit issue N 4 unit:3 at 3,40 kronor with first day 5/9, where each unit consisted of one share and one subscription option.
Separately, on 30 June 2026 a consortium through HealthCo Oy announced a public takeover offer for all outstanding Aino Health shares at 0,2 kronor cash per share, conditional among other things on reaching more than 90 per cent of the shares after full dilution. The acceptance period was expected to run from around 1 July to around 10 August 2026; the bidder completed the offer on 11 August, declared it unconditional, and extended the acceptance period first to 15 September and then to 13 October 2026 for shareholders who had not yet accepted. An earlier 2023 mandatory offer from Norberg & Partner at 0,41 kronor cash per share is also recorded. Holders who subscribed in the issue and later tendered shares will need both the subscription figures and the offer prices for their gain calculations.
No new Allmänna råd are recorded for the share: the page states that none currently exist. The operative new facts for 2026 disposals are therefore the ratio N 1:3, the price 0,20 kronor and the ex-rights date 17/11.
Legal basis is Skatteverket's published share history for Aino Health AB, "Emissioner m.m.", new 2026 row.
Shareholders disposing of Aino Health shares in 2026 should apply the new N 1:3 at 0,20 kr terms with ex-rights date 17/11 when computing average acquisition cost.